II Ugp Llc Mithril serves as Executive at Adagio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, II Ugp Llc Mithril has executed 2 insider transactions totaling $33.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 10, 2021 involved purchasing 1,997,000 shares valued at $33.9M.
II Ugp Llc Mithril currently holds 11,241,580 shares of Adagio Therapeutics, Inc. (ADGI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, II Ugp Llc Mithril has been a net buyer of ADGI stock. They have purchased $33.9M and sold $0 worth of shares.
II Ugp Llc Mithril's most recent insider trade was on Aug 10, 2021, when they purchased 1,997,000 shares at $17.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |